Cellebrite CLBT 深 滬
等待開盤 06-05 09:30:00 美东时间
14.3394
+0.159
+1.12%
華盛通- 最 高14.64
- 今 開14.29
- 成交量 71.91万股
- 最 低 14.11
- 昨 收 14.18
- 總市值 35.77亿
- 52周最高 19.98
- 市盈率 靜 46.05
- 換手率 0.29%
- 52周最低 11.02
- 委 比 -5.79%
- 總股本 2.49亿
- 歷史最高 26.30
- 量 比 0.35
- 振 幅 3.74%
- 歷史最低 3.80
- 每 手 1
- 風險率 2.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20
DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.
05-27 22:53
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $18 to $15.
05-15 19:34
Cellebrite DI shares are trading higher after the company reported better-than-expected Q1 financial results.
Cellebrite DI shares are trading higher after the company reported better-than-...
05-15 02:51
Cellebrite DI Q1 2026 Earnings Call Transcript
On Thursday, Cellebrite DI (NASDAQ:CLBT) discussed first-quarter financial resu...
05-14 21:52
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Cellebrite Announces First-Quarter 2026 Results
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32% Q2 Outlook Highlights ARR Acceleration TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2026 /PRNewswire/ -- Cellebrit...
05-14 19:00
Cellebrite一季度财报前瞻：AI新品成焦点，营收预期增长18%
数字取证与智能解决方案提供商Cellebrite DI Ltd．将于周四盘前发布2026年第一季度财报。市场普遍预期公司营收将实现两位数增长，但盈利水平可能...
05-14 03:48
Cellebrite Announces FedRAMP High Authorization For Its Cellebrite Government Cloud Platform
Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that its Cellebrite Government Cloud (CGC) platform has
05-06 20:32
